Y-mAbs Therapeutics Inc (YMAB)
13.92
+0.32
(+2.31%)
USD |
NASDAQ |
May 09, 11:25
Y-mAbs Therapeutics Profit Margin (Quarterly): -4.23% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.23% |
| September 30, 2023 | -37.88% |
| June 30, 2023 | -30.37% |
| March 31, 2023 | -31.55% |
| December 31, 2022 | 3.68% |
| September 30, 2022 | -219.6% |
| June 30, 2022 | -380.9% |
| Date | Value |
|---|---|
| March 31, 2022 | -267.7% |
| December 31, 2021 | -384.4% |
| September 30, 2021 | -321.9% |
| June 30, 2021 | -209.5% |
| March 31, 2021 | |
| December 31, 2020 | -96.06% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-384.4%
Minimum
Dec 2021
3.68%
Maximum
Dec 2022
-165.0%
Average
-152.8%
Median
Profit Margin (Quarterly) Benchmarks
| The Cooper Companies Inc | 8.72% |
| Puma Biotechnology Inc | -11.00% |
| Humacyte Inc | -- |
| Moderna Inc | -703.6% |
| NovaBay Pharmaceuticals Inc | -110.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.49% |
| Return on Assets | -16.04% |
| Return on Invested Capital | -20.49% |
| Gross Profit Margin (Quarterly) | 91.27% |
| Operating Margin (Quarterly) | -13.69% |
| Return on Net Operating Assets | -72.37% |